Name

Silodosin

Description

Silodosin is an α1-adrenoceptor antagonist that is selective for the prostate. Silodosin is for symptomatic treatment of benign prostatic hyperplasia. FDA approved Oct 9, 2008.

Brands

Ipca Urosciences

Rapilif

Recordati Industria Chimica e Farmaceutica S.p.A.

Silodyx

Watson Pharmaceuticals Inc.

Urief